单中心WHO III级(间变性)脑膜瘤的纵向诊治经验
回顾性分析2000年3月至2015年6月初治的18例WHO III级间变性脑膜瘤患者,中位无进展生存期14.5个月(95%CI 6.9-22.2),5年生存率40±15%,中位总生存期55.8个月(95%CI 27.7-80.3);仅KPS影响结局(PFS p=0.0003;OS p=0.0003)。
要点
- 18例间变性脑膜瘤中13例(72%)复发、10例(56%)死亡,中位无进展生存期14.5个月。
- 中位总生存期55.8个月,5年生存率40±15%。
- 所分析因素中仅KPS影响PFS(p=0.0003)与OS(p=0.0003)。
核心结论
- 中位总生存期55个月(4.6年),结果与现有间变性脑膜瘤预后不良的报道一致。
- 现有数据显示手术切除后放疗及挽救性放射外科和/或化疗可延长生存,但获益可能随反复治疗而下降。
研究设计与样本
- 单中心回顾性分析18例按WHO 2016定义诊断的III级间变性脑膜瘤患者,初治时间为2000年3月至2015年6月。
主要发现
- 11例(61%)为男性,诊断时中位年龄63岁(范围48-86),10例(55%)体能状态良好(KPS≥80)。
- 8例(45%)在升级为间变性脑膜瘤前为较低级别(I级2例;II级6例)。
- 13例(72%)复发,10例(56%)死亡;中位无进展生存期14.5个月(95%CI 6.9-22.2)。
- 5年生存率40±15%,中位总生存期55.8个月(95%CI 27.7-80.3)。
- 所分析因素中仅KPS影响结局(PFS p=0.0003;OS p=0.0003)。
关键数值与推荐
- 10例初次手术后接受分次放疗,8例接受挽救性分次放疗,1例在初次放疗同时接受立体定向放射外科(SRS)推量。
- 14例接受挽救性SRS治疗18个独立区域。
- 挽救性化疗主要考虑用于第三或第四次复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To retrospectively analyze and assess the outcomes and prognostic factors in patients with anaplastic meningioma (AM) (WHO Grade III). Clinical data and outcome [overall (OS) and progression-free (PFS) survival] from 18 patients with Grade III meningioma (AM, based on World Health Organization 2016 definition) initially treated between March 2000 and June 2015 were analyzed. Eleven patients (61%) were male, median age at diagnosis was 63 (range 48-86), and 55% (10/18 patients) had good performance status (KPS ≥ 80). Eight patients (45%) had lower grade disease (Grade I-n = 2; Grade II-n = 6) prior to being upgraded to AM. Ten patients had fractionated radiation after primary surgery, eight patients had salvage fractionated RT, stereotactic radiosurgery (SRS) boost along with primary RT in 1 patient, and salvage SRS to 18 separate areas in 14 patients. Salvage chemotherapy was mainly considered in third or fourth recurrences. 13 (72%) patients recurred and 10 (56%) have died. Median PFS was 14.5 months (95% CI 6.9-22.2). The 5-year survival rate was 40 ± 15% and median OS was 55.8 months (95% CI 27.7-80.3). Of all factors examined, only Karnofsky performance status (KPS) affected outcome (PFS p = 0.0003; OS p = 0.0003). With median OS of 55 months (4.6 years) our results are consistent with existing reports of the poor outcomes for AM patients. From the available data, surgical resection followed by RT and salvage radiosurgery and/or chemotherapy can lead to extended survival; however the benefit may decrease with successive treatments.
引用
- Balasubramanian SK, Sharma M, Silva D, et al. Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution. J Neurooncol. 2016. PMID: 27864703. doi:10.1007/s11060-016-2321-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。